Literature DB >> 26851247

Hypoxia-induced cardiac injury in dystrophic mice.

Zachary Stelter1, Jana Strakova1, Amritha Yellamilli1, Kaleb Fischer1, Katharine Sharpe1, DeWayne Townsend2.   

Abstract

Duchenne muscular dystrophy (DMD) is a disease of progressive destruction of striated muscle, resulting in muscle weakness with progressive respiratory and cardiac failure. Respiratory and cardiac disease are the leading causes of death in DMD patients. Previous studies have suggested an important link between cardiac dysfunction and hypoxia in the dystrophic heart; these studies aim to understand the mechanism underlying this connection. Here we demonstrate that anesthetized dystrophic mice display significant mortality following acute exposure to hypoxia. This increased mortality is associated with a significant metabolic acidosis, despite having significantly higher levels of arterial Po2 Chronic hypoxia does not result in mortality, but rather is characterized by marked cardiac fibrosis. Studies in isolated hearts reveal that the contractile function of dystrophic hearts is highly susceptible to short bouts of ischemia, but these hearts tolerate prolonged acidosis better than wild-type hearts, indicating an increased sensitivity of the dystrophic heart to hypoxia. Dystrophic hearts display decreased cardiac efficiency and oxygen extraction. Isolated dystrophic cardiomyocytes and hearts have normal levels of FCCP-induced oxygen consumption, and mitochondrial morphology and content are normal in the dystrophic heart. These studies demonstrate reductions in cardiac efficiency and oxygen extraction of the dystrophic heart. The underlying cause of this reduced oxygen extraction is not clear; however, the current studies suggest that large disruptions of mitochondrial respiratory function or coronary flow regulation are not responsible. This finding is significant, as hypoxia is a common and largely preventable component of DMD that may contribute to the progression of the cardiac disease in DMD patients.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  Duchenne muscular dystrophy; dystrophic cardiomyopathy; dystrophin; hypoxia; mitochondria

Mesh:

Substances:

Year:  2016        PMID: 26851247      PMCID: PMC4865065          DOI: 10.1152/ajpheart.00917.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  72 in total

1.  Effect of acute hypobaric hypoxia on the histological changes of diaphragm in mice.

Authors:  H Kozłowska; J Rowiński; A Karkucińska-Wieckowska
Journal:  Folia Histochem Cytobiol       Date:  1999       Impact factor: 1.698

2.  Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands.

Authors:  K Bushby; F Muntoni; A Urtizberea; R Hughes; R Griggs
Journal:  Neuromuscul Disord       Date:  2004-09       Impact factor: 4.296

3.  Dystrobrevin increases dystrophin's binding to the dystrophin-glycoprotein complex and provides protection during cardiac stress.

Authors:  Jana Strakova; Jon D Dean; Katharine M Sharpe; Tatyana A Meyers; Guy L Odom; DeWayne Townsend
Journal:  J Mol Cell Cardiol       Date:  2014-08-24       Impact factor: 5.000

4.  Inhibiting TGF-β activity improves respiratory function in mdx mice.

Authors:  Carol A Nelson; R Bridge Hunter; Lindsay A Quigley; Stefan Girgenrath; William D Weber; Jennifer A McCullough; Carol J Dinardo; Kelly A Keefe; Lorena Ceci; Nicholas P Clayton; Alison McVie-Wylie; Seng H Cheng; John P Leonard; Bruce M Wentworth
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

5.  Nocturnal hypoxaemia and hypercapnia in children with neuromuscular disorders.

Authors:  Chiara Bersanini; Sonia Khirani; Adriana Ramirez; Frédéric Lofaso; Guillaume Aubertin; Nicole Beydon; Michèle Mayer; Kim Maincent; Michèle Boulé; Brigitte Fauroux
Journal:  Eur Respir J       Date:  2011-12-01       Impact factor: 16.671

6.  Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs.

Authors:  Dewayne Townsend; Immanuel Turner; Soichiro Yasuda; Joshua Martindale; Jennifer Davis; Michael Shillingford; Joe N Kornegay; Joseph M Metzger
Journal:  J Clin Invest       Date:  2010-03-15       Impact factor: 14.808

7.  Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 8.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

9.  Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy.

Authors:  Gail D Thomas; Jianfeng Ye; Claudio De Nardi; Angela Monopoli; Ennio Ongini; Ronald G Victor
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

10.  Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice.

Authors:  K Ohlendieck; K P Campbell
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

View more
  3 in total

Review 1.  Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923

2.  Ischemia/hypoxia inhibits cardiomyocyte autophagy and promotes apoptosis via the Egr-1/Bim/Beclin-1 pathway.

Authors:  Bo Su; Xian-Tao Wang; Yu-Han Sun; Man-Yun Long; Jing Zheng; Wen-Hao Wu; Lang Li
Journal:  J Geriatr Cardiol       Date:  2020-05       Impact factor: 3.327

3.  A 1H-NMR approach to myocardial energetics.

Authors:  Jackie A Heitzman; Tyler C Dobratz; Kaleb D Fischer; DeWayne Townsend
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.